U.S. computer-aided detection (CAD) is a technology designed to reduce observational oversights during the diagnosis of harmful lesions. Computer-aided detection (CAD) utilizes a set of algorithms to identify and detect harmful lesions present in the breast. It is also used for the diagnosis of lung cancer, colon cancer, prostate cancer, bone metastases, coronary artery disease, and other diseases. The increasing prevalence of breast cancer is expected to propel the growth of the U.S. computer-aided detection (CAD) market over the forecast period.

Market Dynamics

Increasing demand for computer-aided detection (CAD) solutions in multidisciplinary facilities is expected to aid in the growth of the market. CAD in it installations are increasing in multispecialty hospitals. Versatile diagnostic systems are preferred in multispecialty hospitals, owing to benefits such as cost-effectiveness and greater return on investment.

Key features of the study:

• This report provides an in-depth analysis of the U.S. computer-aided detection (CAD)market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the U.S. computer-aided detection (CAD) market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study are iCAD, Inc., Koninklijke Philips N.V., Holojic, Inc., Carestream Health, Inc., Siemens AG, GE Healthcare, EDDA Technology, Inc., EDDA Technology, Inc., and other prominent players.
• Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The U.S. computer-aided detection (CAD) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S. computer-aided detection (CAD) market

Detailed Segmentation:

• U.S. Computer-Aided Detection (CAD) Market, By Product Type:
  • Breast CAD
  • Abdominal CAD
  • Prostrate CAD
  • Cardiovascular CAD
  • Others
• U.S. Computer-Aided Detection (CAD) Market, By Imaging Modality:
  • Mammography
  • X-Ray Imaging
  • MRI
  • Computed Tomography
  • Ultrasound
  • Others
• Company Profiles
  • iCAD, Inc.*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Koninklijke Philips N.V.
  • Holojiic, Inc.
  • Carestream Haelth, Inc.
  • Siemens AG
  • GE Healthcare
  • EDDA Technology, Inc.
  • Fujifilm Holdings Corporation

 “*” marked represents similar segmentation in other categories in the respective section.